Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 62332-744

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 62332-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Capsules (Chlordiazepoxide Clidinium Capsules)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP with a strength of 5 mg/2.5 mg. The label indicates the prescription status (Rx only), package quantity of 100 capsules, and manufacturer Alembic Pharmaceuticals Inc. It includes dosing information, storage instructions, and a barcode with NDC 62332-744-31.*

FDA Label Image

Chlordiazepoxide-clidinium-str1.jpg (Chlordiazepoxide Clidinium Str1)

Chemical structure of chlordiazepoxide hydrochloride, showing a benzodiazepine core with a chlorine substitution and hydrochloride indicated separately.*

FDA Label Image

Chlordiazepoxide-clidinium-str2.jpg (Chlordiazepoxide Clidinium Str2)

Chemical structure of chlordiazepoxide hydrochloride and clidinium bromide shown as a molecular diagram depicting the arrangement of atoms and bonds in the combined active ingredients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.